NCT05946369View on ClinicalTrials.gov

Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer

CompletedOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

January 1, 2023

Study Completion Date

May 1, 2023

Conditions
Urinary Bladder CancerUrinary Bladder NeoplasmBCGTrans Urethral Resection of a Bladder TumorNon-Muscle Invasive Bladder Urothelial Carcinoma
Interventions
DIAGNOSTIC_TEST

Neutrophil to lymphocyte ratio

Complete blood count with differential to evaluate the Neutrophil to lymphocyte ratio for each patient

Trial Locations (1)

11367

Ain Shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05946369 - Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter